Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 818

1.

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.

Mactier S, Kaufman KL, Wang P, Crossett B, Pupo GM, Kohnke PL, Thompson JF, Scolyer RA, Yang JY, Mann GJ, Christopherson RI.

Pigment Cell Melanoma Res. 2014 Jul 4. doi: 10.1111/pcmr.12290. [Epub ahead of print]

PMID:
24995518
[PubMed - as supplied by publisher]
2.

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.

Fogarty GB, Hong A, Jacobsen KD, Reisse CH, Shivalingam B, Burmeister B, Haydu LE, Paton E, Thompson JF.

BMC Res Notes. 2014 Jun 30;7(1):412. doi: 10.1186/1756-0500-7-412.

PMID:
24981506
[PubMed - in process]
Free PMC Article
3.

Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.

Jayawardana K, Schramm SJ, Haydu L, Thompson JF, Scolyer RA, Mann GJ, Müller S, Yang JY.

Int J Cancer. 2014 Jun 27. doi: 10.1002/ijc.29047. [Epub ahead of print]

PMID:
24975271
[PubMed - as supplied by publisher]
4.

DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.

Marzese DM, Scolyer RA, Roqué M, Vargas-Roig LM, Huynh JL, Wilmott JS, Murali R, Buckland ME, Barkhoudarian G, Thompson JF, Morton DL, Kelly DF, Hoon DS.

Neuro Oncol. 2014 Jun 26. pii: nou107. [Epub ahead of print]

PMID:
24968695
[PubMed - as supplied by publisher]
5.

International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin.

Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS.

Ann Surg Oncol. 2014 Jun 25. [Epub ahead of print]

PMID:
24962937
[PubMed - as supplied by publisher]
6.

Lymphatic drainage patterns from primary cutaneous tumours of the forehead: Refining the recommendations for selective neck dissection.

Wiener M, Uren RF, Thompson JF.

J Plast Reconstr Aesthet Surg. 2014 Aug;67(8):1038-44. doi: 10.1016/j.bjps.2014.04.017. Epub 2014 May 20.

PMID:
24927861
[PubMed - in process]
7.

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma.

Carlino MS, Haydu LE, Kakavand H, Menzies AM, Hamilton AL, Yu B, Ng CC, Cooper WA, Thompson JF, Kefford RF, O'Toole SA, Scolyer RA, Long GV.

Br J Cancer. 2014 Jul 15;111(2):292-9. doi: 10.1038/bjc.2014.287. Epub 2014 Jun 10.

PMID:
24918823
[PubMed - in process]
8.

A highly recurrent RPS27 5'UTR mutation in melanoma.

Dutton-Regester K, Gartner JJ, Emmanuel R, Qutob N, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Scolyer RA, Mann GJ, Thompson JF, Hayward NK, Samuels Y.

Oncotarget. 2014 May 30;5(10):2912-7.

PMID:
24913145
[PubMed - in process]
Free PMC Article
9.

Primary Melanoma Location on the Scalp is an Important Risk Factor for Brain Metastasis: A Study of 1,687 Patients with Cutaneous Head and Neck Melanomas.

Huismans AM, Haydu LE, Shannon KF, Quinn MJ, Saw RP, Spillane AJ, Stretch JR, Thompson JF.

Ann Surg Oncol. 2014 Jun 10. [Epub ahead of print]

PMID:
24912613
[PubMed - as supplied by publisher]
10.

Sentinel-node biopsy in melanoma.

Thompson JF, Cochran AJ, Faries MB.

N Engl J Med. 2014 May 29;370(22):2149-50. doi: 10.1056/NEJMc1402989. No abstract available.

PMID:
24869726
[PubMed - indexed for MEDLINE]
Free Article
11.

Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening.

Hill JW, Thompson JF, Carter MB, Edwards BS, Sklar LA, Rosenberg GA.

PLoS One. 2014 May 7;9(5):e96761. doi: 10.1371/journal.pone.0096761. eCollection 2014.

PMID:
24804769
[PubMed - in process]
Free PMC Article
12.

Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease.

van der Ploeg AP, Haydu LE, Spillane AJ, Scolyer RA, Quinn MJ, Saw RP, Shannon KF, Stretch JR, Thompson JF.

Ann Surg Oncol. 2014 May 7. [Epub ahead of print]

PMID:
24802907
[PubMed - as supplied by publisher]
13.

Sentinel lymph node mapping for defining site and extent of elective radiotherapy management of regional nodes in Merkel cell carcinoma: a pilot case series.

Naehrig D, Uren RF, Emmett L, Ioannou K, Hong A, Wratten C, Thompson JF, Hruby G.

J Med Imaging Radiat Oncol. 2014 Jun;58(3):353-9. doi: 10.1111/1754-9485.12180. Epub 2014 Apr 29.

PMID:
24774508
[PubMed - in process]
14.

Pathology review significantly affects diagnosis and treatment of melanoma patients: an analysis of 5011 patients treated at a melanoma treatment center.

Niebling MG, Haydu LE, Karim RZ, Thompson JF, Scolyer RA.

Ann Surg Oncol. 2014 Jul;21(7):2245-51. doi: 10.1245/s10434-014-3682-x. Epub 2014 Apr 19.

PMID:
24748128
[PubMed - in process]
15.

Primary oesophageal melanoma - a case report.

Song EJ, Scolyer RA, Damian DL, Thompson JF.

World J Surg Oncol. 2014 Mar 31;12:77. doi: 10.1186/1477-7819-12-77.

PMID:
24679002
[PubMed - in process]
Free PMC Article
16.

Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.

van der Ploeg AP, Haydu LE, Spillane AJ, Quinn MJ, Saw RP, Shannon KF, Stretch JR, Uren RF, Scolyer RA, Thompson JF.

Ann Surg. 2014 Jul;260(1):149-57. doi: 10.1097/SLA.0000000000000500.

PMID:
24633018
[PubMed - in process]
17.

Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.

Kakavand H, Crainic O, Lum T, O'Toole SA, Kefford RF, Thompson JF, Wilmott JS, Long GV, Scolyer RA.

Pathology. 2014 Apr;46(3):193-8. doi: 10.1097/PAT.0000000000000077.

PMID:
24614711
[PubMed - in process]
18.

The role of sentinel lymph node biopsy in patients with merkel cell carcinoma: uncertainty prevails.

Thompson JF, Hruby G.

Ann Surg Oncol. 2014 May;21(5):1517-9. doi: 10.1245/s10434-014-3587-8. Epub 2014 Mar 7. No abstract available.

PMID:
24604582
[PubMed - in process]
19.

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.

Balch CM, Thompson JF, Gershenwald JE, Soong SJ, Ding S, McMasters KM, Coit DG, Eggermont AM, Gimotty PA, Johnson TM, Kirkwood JM, Leong SP, Ross MI, Byrd DR, Cochran AJ, Mihm MC Jr, Morton DL, Atkins MB, Flaherty KT, Sondak VK.

Ann Surg Oncol. 2014 Apr;21(4):1075-81. doi: 10.1245/s10434-013-3464-x. Epub 2014 Feb 15.

PMID:
24531700
[PubMed - in process]
20.

Isolated limb infusion with melphalan and actinomycin D for melanoma: a systematic review.

Kroon HM, Huismans AM, Kam PC, Thompson JF.

J Surg Oncol. 2014 Mar;109(4):348-51. doi: 10.1002/jso.23553. Review.

PMID:
24522939
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk